Bioqual, Inc. (BIOQ)
OTCMKTS · Delayed Price · Currency is USD
43.19
-0.25 (-0.58%)
At close: Jul 10, 2025
Bioqual Market Cap
Bioqual has a market cap or net worth of $38.63 million as of August 26, 2025. Its market cap has decreased by -2.40% in one year.
Market Cap
38.63M
Enterprise Value
44.41M
Revenue
49.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
$43.19
Market Cap Chart
Since October 24, 1990, Bioqual's market cap has increased from 370.55K to 38.63M, an increase of 10,325.00%. That is a compound annual growth rate of 14.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 38.63M | -34.66% |
| Dec 18, 2024 | 59.12M | -19.19% |
| Dec 30, 2022 | 73.16M | -21.35% |
| Dec 31, 2021 | 93.02M | 30.00% |
| Dec 29, 2020 | 71.55M | 72.04% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 636.43M |
| Elite Pharmaceuticals | 594.22M |
| CytoDyn | 388.66M |
| Northwest Biotherapeutics | 357.21M |
| American Oncology Network | 357.05M |